- All
- Featured news
- News
20Jan2023
New mass spectrometry (MS) characterization for an accurate identification of oligonucleotide impurities
From peptides to oligonucleotides, we successfully transfer and adapt our know-how in developing and...
02Jan2023
New Site Manager at Bachem Headquarters: Meet Frank Dettner
We are pleased to announce that Frank Dettner will take on the role of Site Manager in Bubendorf (Ba...
16Dec2022
Bachem signs long-term follow-on contract for peptides
Contract signed with a total minimum order volume of CHF 1 billion over a five-year period from 2025...
07Dec2022
On the way to greener SPPS: Replacing DMF
At Bachem, we redesign processes to minimize the use and generation of hazardous substances and redu...
29Nov2022
Bachem in Generics – Leading by experience
With more than 50 years of experience, Bachem has built outstanding regulatory expertise to provide ...
25Nov2022
Inspiring today’s youth for science and technology
Bachem is pleased to support the SimplyNano project as a partner. The project aims to get young peop...
Careers
At Bachem, we believe that our employees make the difference. Representing our corporate culture of passion and commitment, they are the foundation of our success. We therefore strive to attract, retain, and develop highly motivated, well-qualified individuals.
View all jobs
Click here >>
Contact
We look forward to partnering with you to build up your project development plan for CMC development according to your unique needs.
No matter what stage your NCE is in – pre-IND, early or late clinical stages, or already on the market – contact us to find out what we can do for you.